Gabelli & CO Investment Advisers, Inc. Corcept Therapeutics Inc Transaction History

Gabelli & CO Investment Advisers, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$16.78 - $27.3 $224,852 - $365,820	-13,400 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$12.46 - $19.98 $14,952 - $23,976	-1,200 Reduced 8.22%	13,400 $233,000
Q1 2018 May 09, 2018	SELL	$14.59 - $25.5 $35,016 - $61,200	-2,400 Reduced 14.12%	14,600 $240,000
Q4 2017 Feb 02, 2018	SELL	$15.77 - $20.72 $14,193 - $18,648	-900 Reduced 5.03%	17,000 $307,000
Q3 2017 Nov 01, 2017	BUY	$12.3 - $19.3 $220,170 - $345,470	17,900	17,900 $345,000

368

86.8M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.29B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.